Durvalumab consolidates treatment breakthroughs: Significantly prolongs the survival of confined small cell lung cancer 26/09/2025
Zenocutuzumab: FDA approves new bispecific antibody for the treatment of NRG1 gene fusion cancer 19/09/2025
A new drug for pancreatic cancer has emerged! Zenocutuzumab offers rapid and long-lasting treatment responses. 20/06/2022 Lung cancer HER3 gene
Lung cancer brain metastasis control rate reaches 80%! Recent research results of the HER3-targeted new drug U3-1402 are impressive. 20/06/2022 Lung cancer HER3 gene
Lung cancer brain metastasis control rate reaches 80%! Recent research results of the HER3-targeted new drug U3-1402 are impressive. 09/06/2022 Lung cancer HER
